Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$401M |
| 2 |
NVIDIA
NVDA
|
$333M |
| 3 |
Costco
COST
|
$236M |
| 4 |
Amazon
AMZN
|
$215M |
| 5 |
Johnson & Johnson
JNJ
|
$160M |
Top Sells
| 1 |
Broadcom
AVGO
|
$322M |
| 2 |
Super Micro Computer
SMCI
|
$284M |
| 3 |
JPMorgan Chase
JPM
|
$178M |
| 4 |
WIRE
Encore Wire Corp
WIRE
|
$160M |
| 5 |
Intel
INTC
|
$152M |
Sector Composition
| 1 | Technology | 19.73% |
| 2 | Financials | 17.51% |
| 3 | Industrials | 12.49% |
| 4 | Consumer Discretionary | 10.71% |
| 5 | Healthcare | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3201
scPharmaceuticals
SCPH
$299M
| $151K | ﹤0.01% |
33,152
-101,928
| -75% | -$465K |
|
3202
Flexible Solutions
FSI
$120M
| $151K | ﹤0.01% |
41,482
+7,408
| +22% | +$27K |
|
3203
US Global Investors
GROW
$31.8M
| $149K | ﹤0.01% |
57,606
+17,239
| +43% | +$44.5K |
|
|
AZUL
3204
DELISTED
Azul
AZUL
| $149K | ﹤0.01% |
45,169
| – | – |
|
3205
The Beauty Health Co
SKIN
$260M
| $146K | ﹤0.01% |
101,476
| – | – |
|
3206
Grupo Aval
AVAL
$3.93B
| $145K | ﹤0.01% |
71,087
-189
| -0.3% | -$386 |
|
3207
Zynex
ZYXI
$45.1M
| $144K | ﹤0.01% |
17,673
+4
| +0% | +$33 |
|
3208
KLX Energy Services
KLXE
$33.7M
| $143K | ﹤0.01% |
26,215
| – | – |
|
3209
Athira Pharma
ATHA
$15.4M
| $143K | ﹤0.01% |
321,447
-228,906
| -42% | -$102K |
|
3210
Barnwell Industries
BRN
$11.5M
| $143K | ﹤0.01% |
63,242
+795
| +1% | +$1.8K |
|
3211
Acumen Pharmaceuticals
ABOS
$87.2M
| $140K | ﹤0.01% |
56,556
+8
| +0% | +$20 |
|
3212
Home Federal Bancorp
HFBL
| $140K | ﹤0.01% |
11,036
-113
| -1% | -$1.43K |
|
|
LOGC
3213
DELISTED
ContextLogic
LOGC
| $139K | ﹤0.01% |
25,580
+7,881
| +45% | +$43K |
|
3214
Santander
BSBR
$40.6B
| $138K | ﹤0.01% |
26,227
-3,840
| -13% | -$20.2K |
|
3215
Lantern Pharma
LTRN
$46.5M
| $138K | ﹤0.01% |
37,548
+19,135
| +104% | +$70.2K |
|
3216
Verastem
VSTM
$663M
| $137K | ﹤0.01% |
45,761
-333
| -0.7% | -$995 |
|
3217
Forafric Global
AFRI
$221M
| $135K | ﹤0.01% |
11,879
| – | – |
|
3218
Apyx Medical
APYX
$74.1M
| $134K | ﹤0.01% |
108,282
-17,545
| -14% | -$21.7K |
|
3219
MediciNova
MNOV
$63.3M
| $129K | ﹤0.01% |
61,285
-8,087
| -12% | -$17K |
|
3220
HilleVax
HLVX
$105M
| $128K | ﹤0.01% |
72,581
-80,021
| -52% | -$141K |
|
3221
Backblaze
BLZE
$491M
| $127K | ﹤0.01% |
19,905
| – | – |
|
3222
BRF SA
BRFS
$5.86B
| $123K | ﹤0.01% |
28,225
+4,777
| +20% | +$20.9K |
|
3223
Ovid Therapeutics
OVID
$87.5M
| $123K | ﹤0.01% |
104,011
-170,971
| -62% | -$202K |
|
3224
Lexicon Pharmaceuticals
LXRX
$396M
| $119K | ﹤0.01% |
76,086
| – | – |
|
3225
Oramed Pharmaceuticals
ORMP
$91.4M
| $119K | ﹤0.01% |
48,805
+17,335
| +55% | +$42.3K |
|